| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 07/20/2006 | US20060160835 Methods and compositions for treatment of central nervous system disorders |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160829 Thienopyrimidine compounds and use thereof |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/20/2006 | US20060160779 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin d derivative |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160745 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060159760 Drug composition having active ingredient adhered at high concentration to spherical core |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159719 Method and composition for inhibiting cardiovascular cell proliferation |
| 07/20/2006 | US20060159711 Therapeutic agent for hemorrhoidal disease |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | CA2594709A1 Intravenous formulations of pde-5 inhibitors |
| 07/19/2006 | EP1681353A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
| 07/19/2006 | EP1681304A2 Recombinant fusion proteins of growth hormone and serum albumin |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1681061A1 Composition for treating apnea, snoring and sleep disorders |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1532124B1 Use of nitrile derivatives as medicament. |
| 07/19/2006 | EP1492769B1 Novel process for the preparation of 1-phenyl-2-(2-pyridyl)ethanamine |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1463812A4 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1393277B1 USE OF NF-Kappa-B INHIBITORS TO TREAT DRY EYE DISORDERS |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1372640B1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1276880B1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1223930B1 Treatment of dyskinesia |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/19/2006 | EP1075492B1 Melanocortin 1 receptor selective compounds |
| 07/19/2006 | EP1056452B1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 07/19/2006 | EP0898580B1 Methods and means for inhibition of cdk4 activity |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | CN1805751A Methods of managing the symptoms of premenstrual syndrome. |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803806A Preparation of ekb-569 and related intermediates |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803193A Use of stroma stem cell derived from bone marrow in preparing formulation for treating hypoxic ischemic cerebral palsy |
| 07/19/2006 | CN1803157A Traditional Chinese medicine composition for restoring consciousness and expelling worms and preventing moth, and the fragrant bag containing same |
| 07/19/2006 | CN1803132A Ramatroban pharmaceutical composition |
| 07/19/2006 | CN1264978C Alpha-amylase activity inhibitors |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264847C 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/19/2006 | CN1264844C 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/19/2006 | CN1264838C Indole derivatives for treating central nervous system disease |
| 07/19/2006 | CN1264836C Benzoaxathiepin derivatives and their use in preparation of medicine |
| 07/19/2006 | CN1264827C 1-cyclic amino-alkylcyclohexane compounds as NMDA receptor antagonist |
| 07/19/2006 | CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II |
| 07/19/2006 | CN1264824C Quinazoline derivatives |
| 07/19/2006 | CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/19/2006 | CN1264565C Anti-senility plaster and its preparation method |
| 07/19/2006 | CN1264552C Preparation of preventing osteoporosis and delaying senility and its preparation process |
| 07/19/2006 | CN1264420C Fire purging medicine and its preparation |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078537 Phenylalkyl diamine and amide analogs |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/18/2006 | US7078437 suppressing degradation of apolipoprotein D to prevent schizophrenia or other diseases caused by denaturation or cell damage in the nervous system, such as Alzheimer's disease, Niemann-Pick disease type C and Unverrichit-Lundborg disease by administering lauric acid or oleic acid |
| 07/18/2006 | US7078436 Administering halosubstitured phenyl alkyl carbamate compound for therapy of anxiety |
| 07/18/2006 | US7078429 Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078412 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, particularly bromide or trifluoroacetate, for treatment of respiratory disorders, alone or in combination with other bronchodilatory compounds |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078394 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen as above and a progestogen equivalent to 90 mu g per day of norgestimate. |
| 07/18/2006 | US7078386 Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone |
| 07/18/2006 | US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell |
| 07/18/2006 | US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture |